Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, we are advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
For more information about Entrada, please visit our website, www.entradatx.com
Company Details
- Employees
- 191
- Founded
- -
- Address
- One Design Center, Boston,ma 02210,united States
- in****@****atx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- entradatx.com
- Keywords
- in leading medical affairs for pre-commercial and commercial therapies for neuromuscular disorders.
- HQ
- Boston, MA
Entrada Therapeutics Questions
Entrada Therapeutics's website is entradatx.com
Entrada Therapeutics's LinkedIn profile is https://www.linkedin.com/company/entradatx
Entrada Therapeutics has
191 employees.
View email and phone details for 191
employees at Entrada Therapeutics.
Entrada Therapeutics's industry is
Biotechnology Research
Entrada Therapeutics's top competitors are
Dyne Therapeutics,
Verve Therapeutics,
Intellia Therapeutics, Inc.,
Sage Therapeutics,
Tessera Therapeutics,
Beam Therapeutics,
Alnylam Pharmaceuticals,
Kymera Therapeutics,
Sarepta Therapeutics,
Vertex Pharmaceuticals.
Entrada Therapeutics's support email address is info@entradatx.com
Entrada Therapeutics's categories are Biotechnology Research
Entrada Therapeutics's founding year is 2016
